학술논문
Update: Influenza Activity in the United States During the 2017-18 Season and Composition of the 2018-19 Influenza Vaccine.
Document Type
Journal Article
Author
Garten, Rebecca; Blanton, Lenee; Elal, Anwar Isa Abd; Alabi, Noreen; Barnes, John; Biggerstaff, Matthew; Brammer, Lynnette; Budd, Alicia P.; Burns, Erin; Cummings, Charisse N.; Davis, Todd; Garg, Shikha; Gubareva, Larisa; Jang, Yunho; Kniss, Krista; Kramer, Natalie; Lindstrom, Stephen; Mustaquim, Desiree; O'Halloran, Alissa; Sessions, Wendy
Source
Subject
*INFLUENZA
*INFLUENZA viruses
*INFLUENZA vaccines
*HOSPITAL care
*PNEUMONIA-related mortality
*CHILD mortality
*
*
*
*
*
Language
ISSN
0149-2195
Abstract
The United States 2017-18 influenza season (October 1, 2017-May 19, 2018) was a high severity season with high levels of outpatient clinic and emergency department visits for influenza-like illness (ILI), high influenza-related hospitalization rates, and elevated and geographically widespread influenza activity across the country for an extended period. Nationally, ILI activity began increasing in November, reaching an extended period of high activity during January-February, and remaining elevated through March. Influenza A(H3N2) viruses predominated through February and were predominant overall for the season; influenza B viruses predominated from March onward. This report summarizes U.S. influenza activity* during October 1, 2017-May 19, 2018.†. [ABSTRACT FROM AUTHOR]